Author:
Chen Pengfei,Zhang Chi,He Liuliang,Li Mingfei,Rong Jie,Sun Pengfei,Chen Yingying,Li Daifeng
Abstract
AbstractPhotothermal immunotherapy is regarded as the ideal cancer therapeutic modality to against malignant solid tumors; however, its therapeutic benefits are often modest and require improvement. In this study, a thermoresponsive nanoparticle (BTN@LND) composed of a photothermal agent (PTA) and pyroptosis inducer (lonidamine) were developed to enhance immunotherapy applications. Specifically, our “two-step” donor engineering strategy produced the strong NIR-II-absorbing organic small-molecule PTA (BTN) that exhibited high NIR-II photothermal performance (ε1064 = 1.51 × 104 M−1 cm−1, η = 75.8%), and this facilitates the diagnosis and treatment of deep tumor tissue. Moreover, the fabricated thermally responsive lipid nanoplatform based on BTN efficiently delivered lonidamine to the tumor site and achieved spatiotemporal release triggered by the NIR-II photothermal effect. In vitro and in vivo experiments demonstrated that the NIR-II photothermal therapy (PTT)-mediated on-demand release of cargo effectively faciliated tumor cell pyroptosis, thereby intensifying the immunogenic cell death (ICD) process to promote antitumor immunotherapy. As a result, this intelligent component bearing photothermal and chemotherapy can maximally suppress the growth of tumors, thus providing a promising approach for pyroptosis/NIR-II PTT synergistic therapy against tumors.
Graphical Abstract
Funder
the National Natural Science Foundation of China
Young Elite Scientists Sponsorship Program by China Association for Science and Technology
Natural Science Fund for Excellent Young Scholars of Henan Province
Youth Talent Promotion Project of Henan Province
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Zhang Z, Kang M, Tan H, Song N, Li M, Xiao P, Yan D, Zhang L, Wang D, Tang BZ. The fast-growing field of photo-driven theranostics based on aggregation-induced emission. Chem Soc Rev. 1983;2022:51.
2. Overchuk M, Weersink RA, Wilson BC, Zheng G. Photodynamic and photothermal therapies: synergy opportunities for nanomedicine. ACS Nano. 2023;17:7979–8003.
3. Wang H, Xue K, Yang Y, Hu H, Xu J, Zhang X. In situ hypoxia-induced supramolecular perylene diimide radical anions in tumors for photothermal therapy with improved specificity. J Am Chem Soc. 2022;144:2360–7.
4. Yang N, Cao C, Li H, Hong Y, Cai Y, Song X, Wang W, Mou X, Dong X. Polymer-based therapeutic nanoagents for photothermal-enhanced combination cancer therapy. Small Struct. 2021;2:2100110.
5. Zeng S, Wang Y, Chen C, Kim H, Liu X, Jiang M, Yu Y, Kafuti YS, Chen Q, Wang J, Peng X, Li H, Yoon J. An ER-targeted, viscosity-sensitive hemicyanine dye for the diagnosis of nonalcoholic fatty liver and photodynamic cancer therapy by activating pyroptosis pathway. Angew Chem Int Ed. 2024;63: e202316487.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献